Jinyu Bio-technology Co., Ltd. (SHSE: 600201)
Health Care · Biotechnology · CN
CN¥11.84
+1.98% today · +16.5% 1Y
Jinyu Bio-technology Co., Ltd. (SHSE: 600201) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.93B and employs 1,881 people.
Over the last twelve months the share price has gained 16.5%, trading between 9.62 and 19.00.
Tweenvest scores Jinyu Bio-technology Co., Ltd. across four factors: quality 73/100, value 30/100, growth 0/100, dividend 38/100. Its strongest factor is quality.
600201 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.93B
- Revenue (TTM)
- $225.72M
- P/E
- 92.99
- EPS
- 0.13
- Dividend yield
- 0.31%
- Beta (5Y)
- 0.66
- 52-week high
- CN¥19.00
- 52-week low
- CN¥9.62
- Avg volume (3M)
- —
- Shares outstanding
- 1.09B
- Employees
- 1,881
- Next earnings
- —
About Jinyu Bio-technology Co., Ltd.
Based in Hohhot, China, Jinyu Bio-technology Co., Ltd. is a Chinese firm specializing in the development, production, and commercialization of biological products for animal health. Established in 1992, the company provides crucial vaccines designed to combat diseases such as foot-and-mouth disease, highly pathogenic avian influenza, brucellosis, rabies, and swine fever. These vital immunizations are supplied for a broad spectrum of animals, including pigs, poultry, ruminants, and companion pets. The entity formally adopted its current name, Jinyu Bio-technology Co., Ltd., in December 2015, having previously operated as Inner Mongolia Jinyu Group Co., Ltd.
- ISIN
- CNE000000Y37
- Founded
- 1992
- Listed since
- Jan 15, 1999
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| ABL Bio Inc.KOSDAQ: A298380 | $2.00B | ₩48,000.00 | -6.61% |
| ADARx Pharmaceuticals, Inc.NasdaqGS: ADRX | $1.99B | $17.78 | 0.00% |
| OliX Pharmaceuticals, IncKOSDAQ: A226950 | $1.99B | ₩117,300.00 | +0.43% |
| Vir Biotechnology, Inc.NasdaqGS: VIR | $1.98B | $11.36 | -2.91% |
| Pell Bio-Med Technology Co., Ltd.TWSE: 6949 | $1.92B | NT$46.85 | +5.28% |
| Lakefront Biotherapeutics NVENXTAM: LKFT | $1.92B | €26.32 | +1.70% |
| Agios Pharmaceuticals, Inc.NasdaqGS: AGIO | $1.90B | $31.10 | -2.23% |
| Sarepta Therapeutics, Inc.NasdaqGS: SRPT | $1.89B | $17.56 | -1.62% |
Figures last refreshed Oct 11, 2026.